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Abstract 
The aim was to identify adverse events 
arising from the continued use of 
atypical antipsychotics through cohort 
and case control studies, carried out on 
a worldwide level, in the period from 
2013 and 2014. Method: A literature 
review was performed from an 
exploratory study seeking cohort and 
case control studies about atypical 
antipsychotics with bibliometrics 
application according to Bradford's 
Law. Results: The study resulted in 291 
surveyed articles, of which 18 were 
selected and analyzed. Conclusion: the 
main findings were cardiovascular risk, 
QT interval prolongation, diabetes, 
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increased body mass index, 
extrapyramidal effects. 
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Resumo 
O objetivo foi identificar eventos 
adversos decorrentes do uso contínuo de 
antipsicóticos atípicos através de 
estudos de coorte e de caso-controle, 
realizados em nível mundial, no período 
de 2013 e 2014. Método: foi realizada 
revisão da literatura a partir de um 
estudo exploratório buscando estudos de 
coorte e caso-controle sobre 
antipsicóticos atípicos com aplicação de 
bibliometria, de acordo com a lei de 
Bradford. Resultados: O estudo resultou 
em 291 artigos pesquisados, dos quais 
18 foram selecionados e analisados. 
Conclusão: os principais achados foram 
de risco cardiovascular, prolongamento 
do intervalo QT, diabetes, índice de 
massa corporal aumentada, efeitos 
extrapiramidais. 
 
Palavras-chave: antipsicóticos, 
esquizofrenia, events. 
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Resumen 
El objetivo fue identificar eventos 
adversos derivados de la utilización 
continuada de antipsicóticos atípicos a 
través de estudios de cohortes y caso-
control, llevó a cabo en todo el mundo 
en el período comprendido entre 2013 y 
2014. Método: una revisión de literatura 
se llevó a cabo un estudio exploratorio 
para estudios de cohortes y caso-control 
sobre antipsicóticos atípicos con 
aplicación de bibliometría, según la ley 
de Bradford. Resultados: el estudio 
resultó en los 291 artículos encuestados, 
de los cuales 18 fueron seleccionados y 
analizados. Conclusión: los resultados 
principales fueron de riesgo 
cardiovascular, síndrome de QT largo, 
diabetes, aumento del índice de masa 
corporal, efectos extrapiramidales. 
Palabras clave: antipsicótica, 
esquizofrenia, eventos. 
 
Introduction 
Antipsychotics are used in the 
primary treatment for all stages of 
schizophrenia. They are not absolute 
therapies and their use is not devoid of 
problems. The low therapeutic response 
and side effects are the main causes of 
relapse of patients, impairing the quality 
of life and generating extra care and 
hospital admissions that increase 
treatment costs. One type of 
classification for these drugs is 
according to their typicality, which may 
be typical or atypical. According to the 
Ministry of Health
(1)
 this classification 
is obsolete, but it is observed that its use 
is largely found in the literature
(2)
.
 
 
Schizophrenia is a chronic 
mental illness in which patients have 
difficulty recognizing reality, of 
behaving within the social parameters 
of normality and even to perform self-
care and personal hygiene tasks. It is the 
most serious mental illnesses, affects 
around two million Brazilians and is 
surrounded by taboos and prejudices, 
due to the ignorance of most people 
about this disease
(3)
. 
Atypical antipsychotics (AA) 
have been used increasingly to treat 
patients with a variety of psychotic 
disorders and severe behavioral 
disorders. In the last decade, clinicians 
and researchers are on alert to the 
potential adverse effects from the use of 
AA, which may be related to weight 
gain, hyperlipidemia and glucose 
intolerance. The low therapeutic 
response of antipsychotics and side 
effects are the main causes of relapse of 
patients, impairing the quality of life 
and generating extra care and hospital 
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admissions that increase treatment 
costs
(4-5)
.  
Adverse events are defined as 
unintentional damage, which can lead to 
temporary or permanent disability, 
prolonged hospitalization or death, as a 
result of care provided to the patient and 
not by the evolution of the disease
(6-7)
. 
The cost of treating 
schizophrenia is 1.5 to 3.0% of the 
annual health budget in developed 
countries
(8)
. In a study conducted in 
three health services in the city of São 
Paulo(Brazil) - one state public hospital, 
one hospital that is linked to the Unified 
Health System and one psychosocial 
care center - showed the average direct 
cost medical and hospital of relapse in 
schizophrenia, per patient, which was 
R$ 8,167.58 (US$ 4,083.50) in the state 
public hospital, R$ 4,605.46 (US$ 
2,302.76) in psychosocial care center 
and R$ 2,397.74 (US$ 1,198, 50) in the 
hospital linked to the Unified Health 
System. The main component was the 
daily cost (87% to 98%). The cost with 
atypical antipsychotics was higher than 
that with typical antipsychotics
(9)
. 
Because of the strong relation 
between the use of AA and the 
incidence of adverse events in the 
treatment of schizophrenia, it is 
necessary to characterize these events to 
the appropriate monitoring of patients 
using these drugs. 
The aim of the study was to 
identify adverse events arising from the 
continued use of atypical antipsychotics 
through cohort and case control studies, 
carried out on a worldwide level in the 
years 2013 and 2014. 
 
Methodology 
 
 A literature review was 
performed from an exploratory study 
seeking cohort and case control studies 
about AA with application of 
bibliometry. 
The bibliometry has three basic 
laws: Bradford's Law (periodicals 
productivity), Lotka's Law (authors 
productivity) and Zipf's Law (frequency 
of words occurrence)
(10)
. 
The bibliometry technique was 
applied, according to Bradford's Law. 
The emergence of bibliometry took 
place in the early twentieth century in 
order to study and evaluate the 
production and scientific 
communication activities. Bibliometry 
is understood as the "quantitative 
technique and statistical measurement 
of production index and dissemination 
of scientific knowledge"
(11)
. 
Scientific publications were 
collected using to search the 
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descriptors: antipsicóticos atípicos 
coorte, antipsicóticos atípicos caso 
controle, atypical antipsychotics cohort, 
atypical antipsychotic case control, 
cohorte antipsicóticos atípicos, 
antipsicóticos atípicos casos y controles. 
Searches were conducted in the 
databases US National Library of 
Medicine's® (MEDLINE, PubMed), 
Scientific Electronic Library Online 
(SciELO), Virtual Health Library 
(BVS). 
The inclusion criteria of used 
articles were: have been found by the 
descriptors; published between January 
2013 and December 2014; are published 
in Portuguese, English or Spanish in 
any country in the world; and are 
characterized as cohort studies or case 
control studies. 
The exclusion criteria used were: 
those who not fit as cohort and case 
control studies, not having types of 
adverse events to the AA use and 
articles not available as full text. 
It was found 291 articles in 
Pubmed database by descriptor Atypical 
antipsychotics cohort with 27 in 2013 
and 14 in 2014 (August) and 275 by 
descriptor Atypical antipsychotics case 
control being 15 in 2013 and 6 in 2014. 
In the Scielo database was found only 1 
article. 
Articles in duplicate were 
excluded as well as those who had no 
adverse events to AA use. 
Although they have limitations, 
observational cohort and case-control 
studies were chosen for providing 
evidence on the incidence in chronic 
conditions such as the use of drugs for 
the treatment of psychiatric disorders, in 
the case of schizophrenia. 
 
Results 
 
Through the methodology were 
found 18 articles that fall within the 
established criteria (Table 1). 
 
 
Table 1: Selected articles with their respective authors, countries, years of 
publication and type of study. 
 
Author Article Country Year Type of 
Study 
12 Antipsychotics and the Risk of Diabetes 
Mellitus Type 2 in Children and Youth. 
USA 2013 cohort 
13 Endothelial nitric oxide synthetase genetic 
variants, metabolic syndrome and endothelial 
function in schizophrenia. 
USA 2013 cohort 
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14 Psychotropic drug initiation or increased 
dosage and the acute risk of falls: a 
prospective cohort study of nursing home 
residents. 
USA 2013 cohort 
15 Antipsychotics Prescription and 
Cerebrovascular Events in Italian Older 
Persons. 
Germany 2013 Case 
control 
16 Atypical Antipsychotic Drugs and Pregnancy 
Outcome: A Prospective, Cohort Study. 
Germany 2013 cohort 
17 Investigation of Peripheral Hypothalamic 
Neurohormone Levels in Psychotic Patients. 
Turkey 2013 Case 
control 
18 Risk of incident stroke in patients with 
Alzheimer disease or vascular dementia. 
USA 2013 Case 
control 
19 Antipsychotics and the Risks of Sudden 
Cardiac Death and All- Cause Death: Cohort 
Studies in Medicaid and Dually-Eligible 
Medicaid-Medicare beneficiaries of Five 
States. 
USA 2013 cohort 
20 Risk of Mortality (Including Sudden Cardiac 
Death) and Major Cardiovascular Events in 
Atypical and Typical Antipsychotic Users: A 
Study with the General Practice Research 
Database. 
UK, USA 2013 cohort 
21 Comparative Safety of Antipsychotics: 
Another Look at the Risk of Diabetes. 
Canada 2013 cohort 
22 Length of mechanical restraint following 
haloperidol injections versus oral atypical 
antipsychotics for the initial treatment of 
acute schizophrenia: a propensity-matched 
analysis from the Japanese diagnosis 
procedure combination database. 
Japan 2013 Case 
control 
23 The Association between Cataract Surgery 
and Atypical Antipsychotic Use: A Nested 
Case-Control Study. 
Canada 2013 Case 
control 
24 Associations between risk of mortality and 
atypical antipsychotic use in vascular 
dementia: a clinical cohort study. 
UK 2013 cohort 
25 Older men with dementia are at greater risk 
than women of serious events after initiating 
antipsychotic therapy. 
Canada 2013 cohort 
26 Antipsychotic Drug Use and the Risk of 
Venous Thromboembolism in Elderly 
Patients With Dementia. 
Germany 2013 Case 
control 
27 Depot Typical Antipsychotics versus Oral 
Atypical Antipsychotics in Relapse Rate 
Among Patients with schizophrenia: A Five -
Year Historical Cohort Study. 
Iran 2014 cohort 
28 Atypical antipsychotics and  hyperglycemic 
emergencies: Multicentre, retrospective 
cohort study of  administrative data. 
Canada 2014 cohort 
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29 Predictors of mortality in atypical 
antipsychotic-treated community-dwelling 
elderly patients with behavioural and 
psychological symptoms of dementia: a 
prospective population-based cohort study 
from Italy. 
Italy 2014 cohort 
Source: Elaborated by the authors 
 
 
In the studies were evaluated the 
effects of atypical antipsychotics for 
schizophrenia and other conditions such 
as dementia in the elderly, bipolar 
disorder, etc. The evaluated populations 
are mostly adults and elderly and were 
also present children and pregnant 
women. The works were found only in 
the English language and published in 8 
countries, and in Brazil was not 
identified any study. 
The atypical antipsychotics 
included in the studies are described in 
Figure 1 with the respective article 
numbers. 
 
 
Figure 1 - Number of citation of articles by atypical antipsychotic.
 
Source: Elaborated by the authors 
 
The cohort study of Bobo et 
al.
(12)
 showed an increased risk of 
developing Diabetes Mellitus type 2 in 
children and adolescents using 
risperidone, quetiapine and olanzapine 
(HR = 3.14 [95% CI = 1.50 – 6.56]). In 
another cohort study of Lipscombe et 
al.
(28)
, it was found a higher risk of 
hyperglycemia in elderly patients with 
diabetes using risperidone [adjusted 
hazard ratio, 95% confidence interval 
(CI): 0.69, 0.53 - 0.90]. The risk for 
hyperglycemic emergencies is low after 
the onset of antipsychotic drugs, but 
patients with pre-existing diabetes may 
be at higher risk. The lower risk 
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appeared with the use of quetiapine in 
older patients, but the clinical 
significance of the results requires 
further study. Another cohort study of 
Moisam et al.
(21)
 opposed to the studies 
cited previously because it was not 
shown higher risk of Diabetes type 2 
with the use of atypical antipsychotics 
in adults taking clozapine, olanzapine, 
quetiapine and risperidone. The use of 
antipsychotics was also related to 
cardiac and vascular events. In cohort 
study of Burghardt et al.
(13)
 was 
researched the endothelial dysfunction 
due to loss of genetic protection 
afforded by nitric oxide. A significant 
association was demonstrated, where 
the variant eNOS T-786C (F = 3.65, p = 
0.02) and smoking (F = 6.03, p = 0.01) 
for those without metabolic syndrome, 
contributed to the meaning of the entire 
model (F (6,108) = 3.39, p = 0.004). 
The study was conducted with adult 
patients using AA olanzapine, 
clozapine, quetiapine, risperidone, 
ziprasidone, iloperidone, paliperidone 
and ariprazol. 
A higher risk of transient 
ischemic attack development in patients 
with Alzheimer's disease [4.5 (2.1-9.2) 
CI 95%] was evidenced in the case-
control study of Imfeld et al.
(18)
 with 
elderly patients using risperidone, 
quetiapine and olanzapine. 
In case control study of 
Schemedt and Garbe
(26)
 an increased 
risk of venous thromboembolism (VTE) 
was observed in patients using the 
combination of AA and conventional 
antipsychotics. Increased VTE risk was 
found for current users (OR, 1.23; 
confidence interval of 95% [CI], 1.01 Y 
1.50) and for users with a combination 
of AA and conventional antipsychotics 
(OR, 1.62; 95% CI, 1.15 Y 2.27). In the 
current users of that study, the use was 
associated with an increase of the risk 
(OR, 1.63; 95% CI, 1.10 Y 2.40). In a 
cohort study of Sultana was found that 
the AA use in vascular dementia does 
not significantly increase the mortality 
risk (HR = 1.05) of elderly patients 
using olanzapine, quetiapine and 
risperidone. 
The risk was also identified in 
the cohort study of Thomas et al.
(20)
 that 
identified a higher mortality for any 
cause, cardiac death and sudden cardiac 
death with antipsychotics in general 
compared to non-psychiatric control 
population, but the risk with AA is 
lower than the risk with typical 
antipsychotics. The RR of cardiac 
mortality is 2.39 in patients between 30 
and 64 years of age. 
However, in relation to vascular 
events, was obtained lower association 
with the use of AA for cerebrovascular 
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events (typical OR, 1.3 [95% CI, 0.9 Y 
1.9]; atypical OR, 0.9; [95% CI, 0.7 Y 
1.2]) in cohort study of Franchi et al.
(15)
. 
Yanik et al.
(24)
, in his case-
control study, found an increase in BMI 
(body mass index) of patients using 
risperidone. The treatment led to a 
significant increase in the levels of 
leptin in patients. The increase was 
about 60% after treatment (T 1.68 0.35 
ng / mL) versus before the beginning of 
treatment (T 0.99 0.17 ng / mL), 0.05 
LP. 
Other types of adverse events 
found were: birth defects identified in 
infants born to mothers who used 
olanzapine, clozapine, quetiapine, 
risperidone, ziprasidone, aripiprazole, 
zotepine, amisulpride 
(16,30)
. Postnatal 
disorders (considering exposed live 
births, at least during the last week of 
gestation): cohort study against 
comparison cohort II: crude OR, 4.18 
(95% CI, 2.62 Y 6.65); Adjusted OR 
(95% CI, 3.51 Y 11.10) 6.24; 
Comparison cohort I versus comparison 
cohort II: crude OR, 6.21 (95% CI, 3.54 
Y 10.89); Adjusted OR (95% CI, 2.21 Y 
11.44) 5.03 
(30)
. 
In addition, a protective 
association of the AA use and a lower 
risk of cataract were observed. 
According Pakzad-Vaezi et al.
(23)
, a 
lower cataract surgery rate (adjusted 
proportion, 0.70; 95% of confidence 
interval, 0.65 - 0.75) was found in 
patients taking clozapine, olanzapine , 
quetiapine and risperidone in a case-
control study with an elderly 
population. 
The AA were more effective in 
the acute treatment of schizophrenia. 
There was less need for mechanical 
restraint with adult patients using 
risperidone and olanzapine. Compared 
with the AA group, the relative risk 
(RR) for the haloperidol group was 1.15 
(95% CI, 0.95 - 1.40, p¼ 0.15)
(22)
. 
In Table 2 were cited other 
adverse events and associations 
identified in the articles. 
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Table 2. Adverse events and other associations related to the use of AA and 
respective authors. 
 
Author Adverse events and other associations 
12 Diabetes Mellitus type 2 
13 Endothelial dysfunction 
14 Risk of falling equal to atypical and typical 
15 Lower association of atypical with cerebrovascular events 
16 Postnatal Disorders 
17 Mortality in vascular dementia 
18 Higher risk of transient ischemic attack development in patients with 
Alzheimer's disease 
19 Cardiovascular events and death 
20 Mortality for any cause, cardiac death and sudden cardiac death 
21 It was not demonstrated increased risk of Type 2 Diabetes 
22 Less need for mechanical restraint in the acute treatment of schizophrenia. 
23 Lower risk of developing cataracts 
24 Increased BMI (body mass index) 
25 Risk of serious adverse events (not specified) 
26 Risk of venous thromboembolism 
27 Lower number of relapses with AA oral doses than deposit AT 
28 Hyperglycemia in diabetics 
29 Deaths, Extrapyramidal symptoms, Strokes 
Source: Elaborated by the authors 
 
Discussion 
The AA have unique benefits in 
relation to typical, reduced risk of 
extrapyramidal effects and tardive 
dyskinesia, but its use has been 
associated with the increase of 
cardiovascular risk because of other 
complications such as: weight gain, 
diabetes mellitus and dyslipidemia. 
Because of the association between 
these metabolic alterations and the 
cardiovascular disease, the AA have 
received growing attention from the 
psychiatric literature, and just recently 
clinicians and researchers began to 
assess the relation between the use of 
drugs and schizophrenia within the 
cardiovascular risk context 
(4,12,19-20,21-
24)
. 
The atypical antipsychotics more 
used in the studies are olanzapine, 
risperidone and quetiapine. This is due 
to the highest frequency of use of these 
drugs compared to other atypical, this 
same relation is found in other studies 
(9,12,28)
. 
A study carried out in Santa 
Catarina showed that the antipsychotic 
haloperidol and risperidone presented 
best cost-effectiveness compared to 
olanzapine. Haloperidol is most likely 
to adverse effects, relapses and 
hospitalizations, situations that affect 
the patient's quality of life compared to 
AA, and olanzapine, in spite of showed 
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a higher effectiveness than haloperidol, 
has a higher cost
(32)
. 
Clozapine was also quite found 
in studies what is justified for being the 
reference antipsychotic in refractory 
cases of schizophrenia having greater 
efficacy on positive symptoms of the 
disease
(33)
. However, the use of 
clozapine is associated with a 
significant increase of the risk of 
incident diabetes mellitus 2 compared 
with the use of haloperidol and 
risperidone. Regarding to quetiapine, 
there is less association with the risk of 
incident diabetes mellitus to the use of 
conventional antipsychotic. 
Antipsychotics are related to a 
higher cardiovascular risk. Olanzapine 
has a higher cardiac safety profile 
compared to chlorpromazine and 
haloperidol. Risperidone has cardiac 
safety profile similar to olanzapine, and 
quetiapine is associated with a lower 
risk
(19)
. 
The risk of acute cardiovascular 
event in young and middle-aged 
patients using olanzapine, quetiapine or 
risperidone are similar, being 5.3 / 1000 
to olanzapine, 3.4 to quetiapine and 5.2 
to risperidone, when used as single 
drugs 
(5,31)
. 
The use of AA in the study by 
Wang et al 
(34)
 in Taiwan was associated 
with a decrease in the rate of mortality 
after ischemic stroke by 86% (OR 0.14; 
95% CI 0.12-0.17), however, with 
typical antipsychotics the decrease in 
the mortality rate was 78% (OR = 0.22; 
95% CI 0,18-0,26). 
The association between the use 
of atypical antipsychotics and weight 
gain are due to an early deficiency in 
glucose metabolism induced by these 
drugs (TEFF) and to the increase of 
leptin levels during treatment
(4)
. 
The use of AA can bring risks to 
the fetus during pregnancy. According 
to the Food and Drug Administration 
(FDA), newborns exposed to these 
drugs in the last week of pregnancy are 
at increased risk of postnatal 
disorders
(35)
 .This brings concerns about 
the safety of pregnant women, since the 
prescription of atypical antipsychotics 
before and during pregnancy is 
increasing. However, pregnancy is 
strongly associated with women 
discontinuing treatment with 
antipsychotics
(30)
. 
It was evident that AA may 
represent safer initial options than the 
typical, after the alternative therapies 
have been exhausted
(36). 
 
Conclusion 
In the study were not found 
cohort and case-control articles 
published in Portuguese and Spanish 
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within the search parameters, which 
shows a low production on the subject 
in Latin speaking countries and in the 
period surveyed. 
Most studies were conducted in 
North America and Central Europe 
demonstrating the need for cohort and 
case-control studies in South America 
(Brazil) and Latin America and other 
countries in accordance with the 
socioeconomic and cultural context. 
There is great difficulty in 
managing the treatment of 
schizophrenia, with high rates of relapse 
and modest pattern of improvement in 
efficacy assessments. AA have 
advantages over typical mainly by a 
superior safety profile, which can lead 
to a better treatment compliance. 
The study showed that AA drugs 
are widely used in the world for the 
treatment of schizophrenia and other 
psychiatric diseases. These drugs are 
not immune to adverse events according 
to the Table 3 studies. It is necessary to 
emphasize the need for frequent 
monitoring of antipsychotic users with 
pre-existing morbidities or not. 
The main findings are 
cardiovascular risk, QT interval 
prolongation, diabetes, increased body 
mass index and extrapyramidal effects. 
These effects can lead to relapse of 
patients if not properly monitored, being 
in this case less frequent with AA. 
The contribution of the study 
was to provide more updated and 
systematized information at level of 
clinical evidence about adverse events 
arising from the use of AA, facilitating 
access for multidisciplinary teams and 
health managers. 
Among the study's limitations 
are the difficulty in identifying an 
association between an adverse event 
and a single drug due to poly pharmacy. 
There is no conflict of interest. 
 
References 
 
1. Ministry of Health (BR). 
Department of Health Care. Clinical 
protocols and therapeutic guidelines. 
Schizophrenia. Brasília: Ordinance 
SAS / MS No. 364 of April 9, 2013. 
 
 
2. American Psychiatric Association 
(US). Practice guideline for the 
treatment of patients with 
schizophrenia.http://www.psych.org
/psych_pract/treatg/pg/SchizPG-
Complete-Feb04.pdf, 09, 2006. 
 
3. Palmeira L, Geraldes MT, Bezerra 
AB. Understanding Schizophrenia: 
how the family can help in the 
treatment? Rio de Janeiro: 
Interscience, 2009. 
 
 
4. Jin H , Meyer JM, Mudaliar S , Jeste 
DV. Impact of atypical 
antipsychotic therapy on leptin, 
ghrelin, and adiponectin. 
Revista Eletrônica Gestão & Saúde ISSN: 1982-4785 
Ferreira CAA, Santos ICO, Guimarães HAA et. al   Atypical antipsychotics analysis of... 
Revista Eletrônica Gestão & Saúde. Vol.06, N°. 03, Ano 2015 p. 2870-83  2881 
 
Schizophrenia Research.2008; 100 
(1-3):70–85. 
 
 
5. Gilca M,Piriu G,Gaman L, Delia C, 
Losif L,Atanasiu V, et al. A study of 
antioxidante activity in patients with 
schizophrenia taking atypical 
antipsychotics. 
Psychopharmacology (Berl).2014,1 
-8. 
 
 
6. Mendes W, Travassos C, Martins 
M, Marques PM. Adaptation of 
assessment tools of adverse events 
for use in Brazilian hospitals. Rev 
Bras Epidemiol .2008 Sea; 11 (1): 
55-66. 
 
 
7. Ventura CMU, Alves JGB, Meneses 
JA. Adverse events in Neonatal 
Intensive Care Unit. Rev Bras 
Enferm. 2012 Feb; 65 (1): 49-55. 
 
 
8. Cortesi PA, Mencacci C, Luigi F, 
Pirfo E, Berto P,Sturkenboom 
MCJM, et al. Compliance, 
persistence, costs and quality of life 
in young patients treated with 
antipsychotic drugs: results from the 
COMETA study. BMC Psychiatry 
.2013; 13(98): 2-16. 
 
 
9. Daltio CS, Mari JJ, Ferraz 
BM.Direct medical costs associated 
with schizophrenia relapses in 
health care services in the city of 
São Paulo. Rev Saude Publica. 
2011; 45(1):14-23.  
 
 
10. Souza MTS, Ribeiro HCM. 
Environmental sustainability: a 
meta–analysis of production in 
Brazilian management journals. Rev 
Admin Contemp.2013 mai/jun; 
17(3): 368-396. 
 
 
11. Araújo CA. Bibliometry: 
development, history and current 
issues. Em Questão. 2006; 12 (1): 
11-32. 
 
 
12. Bobo WV, Cooper WO, Stein 
MBM,Olfson M,Graham D, 
Daugherty J, et al. Antipsychotics 
and the Risk of Type 2 diabetes 
Mellitus in Children and Youth. 
JAMA Psychiatry. 
2013;70(10):1067-1075.  
 
 
13. Burghardt K, Grove T, Ellingrod V. 
Endothelial nitric oxide synthetase 
genetic variants, metabolic 
syndrome and endothelial function 
in schizophrenia. Journal of 
psychopharmacology (Oxford, 
England). 2014;28(4):349-356. 
 
 
14. Echt MA, Samelson EJ, Hannan 
MT, Dufour AB, Berry SD. 
Psychotropic drug initiation or 
increased dosage and the acute risk 
of falls: a prospective cohort study 
of nursing home residents. BMC 
Geriatrics. 2013;13(19):2-8. 
 
 
15. Franchi C, Sequi M, Tettamanti M, 
Bonometti F, Nobili Al,Fortino I, et 
al. Antipsychotics Prescription and 
Cerebrovascular Events in Italian 
Older Persons. J. Clin 
Psychopharmacol. 2013 
Aug;33(4):542-5. 
 
 
16. Habernamm F, Fritzsche J, 
Fuhlbru¨ck F, Wacker E, Allignol A, 
Weber-Schoendorfer C, et al. 
Atypical antipsychotic drugs and 
Revista Eletrônica Gestão & Saúde ISSN: 1982-4785 
Ferreira CAA, Santos ICO, Guimarães HAA et. al   Atypical antipsychotics analysis of... 
Revista Eletrônica Gestão & Saúde. Vol.06, N°. 03, Ano 2015 p. 2870-83  2882 
 
pregnancy outocome. A 
prospective,cohort study. Journal of 
clinical psychopharmacology.2013 
aug ;33(4):453-462. 
 
 
17. Sultana J, Chang CK, Hayes RD, 
Broadbent M, Stewart R, Corbett A, 
et al. Associations between risk of 
mortality and atypical antipsychotic 
use in vascular dementia: a clinical 
cohort study. Int J Geriatr 
Psychiatry. 2014;29(12):1249-54. 
 
 
18. Imfeld P, Bodmer M, Schucrh M, 
Jick SS, Meier CR. Risk of incident 
stroke in patients with Alzheimer 
disease or vascular dementia. 
American Academy of  neurology. 
2013 Sept;81(3):910-919. 
 
 
19. Leonard CE, Freeman CP, New 
Comb CW, Bilker WB, Kimmel SE, 
Strom BL, et al. Antipsychotics and 
the risks of sudden cardiac 
death:cohort studies in Medicaid and 
dually-eligible medicaid-medicare 
beneficiaries of five states. J. clin 
Exp Cardiolog .2013;10(6):1-16. 
 
 
20. Murray-Thomas T, Jones ME, 
Deven Patel, Elizabeth Brunner, 
Shatapathy CC, Motsko S, et al. 
Cardiovascular Psychiatry and 
Neurology .2013; 247486:1-16. 
 
 
21. Moisan J, Turgeon M, Desjardins O, 
Grégoire  JP. Comparative safety of 
antipsychotics: another look at the 
risk of diabetes. Can J Psychiatric 
.2012;57(4):218-224. 
 
 
22. Nakamura M, Yasunaga H, 
Haraguchi T, Ando S, Sugihara T, 
Horiguchi H, et al. Length of 
mechanical restriant following 
haloperidol injections versus oral 
atypical antipsychotics for the initial 
treatment of acute schizophrenia: A 
propensity-matched analysis 
procedure combination database. 
Psychiatry Research.2013; 209:412-
416. 
 
 
23. Pakzad-Vaezi RL, Etminan M, 
Mikelberg F. The association 
between cataract sugery and atypical 
antipsychotic use: a nested case-
control study. American Journal of 
Optalmology.2013 
Dec;156(6):1141-1146. 
 
 
24. Yanik T, Kursungoz C, Sutcigil L,  
Ak M . Weight Gain in Risperidone 
Therapy. Journal of Clinical 
Psychopharmacology.2013Oct;33(5
):608-613. 
 
 
25. Rochon PA,  Gruneir A, Sudeep SG, 
Wu W, Fischer HD, Bronskill SE, et 
al. Older Men with Dementia Are at 
Greater Risk than Women of 
Serious Events After Initiating 
Antipsychotic Therapy. Journal The 
American Geriatrics 
Society.2013;61:55-61. 
 
 
26. Schmedt N, Garbe E. Antipsychotic 
Drug Use and the Risk of Venous 
Thromboembolism in Elderly 
Patients With Dementia. Journal of 
Clinical Psychopharmacology.2013 
Dec;33( 6):753-758. 
 
 
27. Almadkhaniha HR, Bani-Hashem S, 
Almadzad-Asl M. Depot typical 
antipsychotics versus oral atypical 
antipsychotics in relapse rate among 
patients with schizophrenia; a five –
year historical cohort study.Iran 
Revista Eletrônica Gestão & Saúde ISSN: 1982-4785 
Ferreira CAA, Santos ICO, Guimarães HAA et. al   Atypical antipsychotics analysis of... 
Revista Eletrônica Gestão & Saúde. Vol.06, N°. 03, Ano 2015 p. 2870-83  2883 
 
J.psychiatry Behav.Sc.2014;8(1):66-
71. 
 
 
28. Lipscombe LL, Austin PC, Alessi-
Severini S, Blackburn DF,Blais L, 
Filion, KB, et al. Atypical 
antipsychotics and hyperglycemic 
emergencies: 
multicenter,retrospective cohort 
study of administrative data. 
Schizophrenia 
Research.2014;154:54-60. 
 
 
29. Rafaniello C, Lombardo F,  
Ferrajolo C, Sportiello L, Parretta E, 
Formica R, et al. Predictors of 
mortality in atypical antipsychotic-
treated community-dwelling elderly 
patients with behavioural and 
psychological symptoms of 
dementia: a prospective population-
based cohort study from Italy. Eur J 
Clin Pharmacol .2014; 70:187–195. 
 
 
30. Petersen I , McCrea RL, Osborn 
DJP, Evans S , Pinfold V , Cowen 
PJ, et al.Discontinuation of 
antipsychotic medication in 
pregnancy: A cohort study. 
Schizophrenia Research.2014; 159: 
218–225. 
 
 
31. Pasternak B, Svantrãm H,Ranthe 
MF,Melbye M, Hviid A. Atypical 
Antipsychotics Olanzapine, 
Quetiapine, and Risperidone and 
Risk of Acute Major Cardiovascular 
Events in Young and Middle-Aged 
Adults: A Nationwide Register-
Based Cohort Study in Denmark. 
Journal CNS drugs .2014;1-11. 
 
 
32. Linder LM, Marasciulo AC, Farias 
MR, Grohs GEM. Economic 
Evaluation of antipsychotic drugs 
for schizophrenia treatment within 
the Brazilian Healthcare. Revista 
Saúde Pública. 2009;43(1):62-9. 
 
 
33. Hong M, Forte G. Agranulocytosis 
induced by interferon-alpha and 
ribavirin in patients with 
schizophrenia taking clozapine. 
Rev. Bras. Psiquiatria.2006; 28 (1): 
84-85. 
 
 
34. Wang JY, Wang CY, Tan CH, Chao 
TT, Huang YS ,  Lee CC. Effect of 
Different Antipsychotic Drugs on 
Short-Term Mortality in Stroke 
Patients. Medicine.2014 
Nov;93(25): 1-6. 
 
 
35. Food Drug Safety Communication; 
FDA: Antipsychotic drug labels 
updated on use during pregnancy 
and risk of abnormal muscle 
movements and withdrawal 
symptoms in newborns; Mar 29, 
2011.  
 
 
36. Jackson JW, Schneeweiss S, 
VanderWeele TJ, Blacker D. 
Quantifying the Role of Adverse 
Events in the Mortality Difference 
between First and Second-
Generation Antipsychotics in Older 
Adults: Systematic Review and 
Meta-Synthesis. PLOS ONE.2014 
Aug;9(8):e105376.
 
 
 
Sources of funding: No  
Conflict of interest: No  
Date of first submission: 2015-02-11 
Last received: 2015-06-15 
Accepted: 2015-07-14 
Publishing: 2015-09-30 
 
